Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study (the APEX II study)
Crossref DOI link: https://doi.org/10.1136/bmjopen-2016-011857
Published Online: 2016-08-09
Published Print: 2016-08
Update policy: https://doi.org/10.1136/crossmarkpolicy
Niven, Robert M
Saralaya, Dinesh
Chaudhuri, Rekha
Masoli, Matthew
Clifton, Ian
Mansur, Adel H
Hacking, Victoria
McLain-Smith, Susan
Menzies-Gow, Andrew
Funding for this research was provided by:
Novartis Pharmaceuticals UK Limited